According to new documents, the University of Illinois at Chicago Institutional Review Board, the committee responsible for protecting research subjects, improperly fast-tracked approval of Dr. Mani Pavuluri’s clinical trial, didn’t catch serious omissions from the consent forms parents had to sign and allowed children to enroll in the study even though they weren’t eligible. Still, UIC officials have continued to blame only Pavuluri, and have downplayed the institution's role in the research.
from Kaiser Health News https://ift.tt/2FoSNWg
March 20, 2019
Rose
Health News, Kaiser Health News
No comments
Related Posts:
State Highlights: In Face Of Growing Soda Tax Movement, California Law May Pre-Empt More Measures; Connecticut Aims To ‘Get To Zero’ On HIV InfectionsMedia outlets report on news from California, Connecticut, Washington, Minnesota, Wisconsin, Ohio, Maryland, Illinois, Arizona, Texas, Kansas, Georgia, Puerto Rico, New Hampshire and Massachusetts. from Kaiser Health News ht… Read More
Different Takes: Kennedy’s Departure Marks End To Abortion Rights; Chief Justice Roberts Unlikely To Overturn Roe V. WadeEditorial pages focus on the pivotal role Justice Anthony Kennedy played in protecting abortion rights, what the future holds for Roe v. Wade and other health issues. from Kaiser Health News https://ift.tt/2lF3QzJ … Read More
Longer Looks: The Court Without Kennedy; The Neuroscience Of Pain; And Medicaid Work RequirementsEach week, KHN's Shefali Luthra finds interesting reads from around the Web. from Kaiser Health News https://ift.tt/2tNgj8c … Read More
Viewpoints: Lessons From Doctors On Caring For Immigrant Children’s Health; Create A Team To Slow Opioid EpidemicOpinion writers look at these and other health topics. from Kaiser Health News https://ift.tt/2tNglNm … Read More
Research Roundup: TV Ads and the Individual Market; Differences in Obesity by DemographicsEach week, KHN compiles a selection of recently released health policy studies and briefs. from Kaiser Health News https://ift.tt/2My7Ugz … Read More
Subscribe to:
Post Comments (Atom)
0 comments:
Post a Comment